Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $45.0000 (5.88%) ($42.5000 - $45.0000) on Wed. Oct. 24, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.01% (three month average) | RSI | 47 | Latest Price | $45.0000(5.88%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CAPR declines -6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -4.005% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.005% (StdDev 8.01%) | Hourly BBV | 0 () | Intraday Trend | 5.9% | | | |
|
1 - 5 Day Possible Target | $29.5(-34.44%) | Resistance Level | $48.04 | 5 Day Moving Average | $43(4.65%) | 10 Day Moving Average | $45.59(-1.29%) | 20 Day Moving Average | $48.04(-6.33%) | To recent high | -39.6% | To recent low | 5.9% | Market Cap | $886m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |